Drug intelligence / Profile preview

Qirong Tablets

Development stage: Unknown
Lead developer: Xi'an Qianhe Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Qirong Tablets (杞蓉片) is a proprietary Traditional Chinese Medicine (TCM) developed and manufactured by Xi'an Qianhe Pharmaceutical. It is an oral herbal formulation primarily composed of *Lycium barbarum* (Goji berry) and *Cistanche deserticola*. In the framework of Traditional Chinese Medicine, it is indicated for tonifying the kidney and replenishing essence, used to treat symptoms such as dizziness, tinnitus, fatigue, and soreness or weakness in the waist and knees. As a multi-component herbal product, its therapeutic profile is derived from the synergistic effects of its botanical constituents rather than a single isolated molecular target. The product is currently approved and marketed in China.

Brand names: Qirong Tablets杞蓉片
Other names: Qirong Pian

Beyond the preview

Go deeper on Qirong Tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qirong Tablets.

Explore the full profile